Abstract digital illustration of a colorful molecular or neural network with interconnected nodes and glowing lines on a dark background

1800x900-istock-2164052892-1

Abstract digital illustration of a colorful molecular or neural network with interconnected nodes and glowing lines on a dark background.

RareCyte

rarecyte-logo-pms7585-coolgray11-r

How can researchers translate spatial transcriptomic discoveries into clinically actionable biomarker panels using multiplex immunofluorescence?

From spatial transcriptomics to spatial protein profiling

Whitepaper

Woman laying hand on her pregnant belly while looking at picture of baby 

istock-669294168

A $500k award will support a two-phase study enrolling pregnant women to advance understanding of placental dysfunction.

RareCyte&reg; announces research grant to investigate molecular profile of circulating trophoblasts in fetal growth restriction

Industry Perspectives

A black, compact laboratory instrument labeled “Orion” and “RareCyte” on its front panel. 

orion-dsc-2641

Tad George, the Senior vice president of Biology at RareCyte, wearing glasses and a blue patterned shirt against a grey wall.

picture-tadgeorge-dsc-2932-crop-250506

Orion 16 channel imaging of a section of salivary gland displaying Goujerot-Sjogren’s Syndrome. 

sjogren-s-syndrome

Recent advancements in imaging technologies are transforming spatial proteomics by enhancing data throughput, resolution, and multiplexing capabilities.

Optimizing spatial proteomics for discovery and translational research

A 3D model of a tumor is shown with red blood vessels and blue and red spots showing the many cells involved in the tumor, against a black background.  

istock-1332513809-1800x900

Learn how spatial profiling and patient-derived models uncover what drives therapy resistance in pancreatic cancer.

Exploring new frontiers in pancreatic cancer treatment with spatial biology

Webinars

ddn-front-cover-december-issue-2025

December 2025

RareCyte provides Precision Biology&trade; products and services for discovery, translational research and clinical diagnostics. The Orion&trade; spatial biology platform enables whole-slide highly multiplexed tissue analysis for multiple samples per day. Comprehensive liquid biopsy offerings enable CTC and other rare cell characterization and single cell retrieval for molecular analysis and CDx development.

How new alternative methods are changing drug safety testing.

88805-yokogawa-tell-us-what-you-know-kr-v2

yokogawa-logo

Yokogawa

&nbsp;Can animal testing be replaced? Discover how scientists are developing more human-relevant ways to predict drug toxicity earlier.

How new alternative methods are changing drug safety testing

Video

White laboratory mouse standing in a petri dish in a laboratory, illustrating a rodent model commonly used in scientific and preclinical studies.

88633-ddn-webinar-inotiv-feb-24-kr1800x900-plain-istock

Inotiv

Learn about common challenges and proper maintenance practices for catheterized rodent models.

Post-surgical management strategies for reliable preclinical rodent studies

Hand reaching toward a glowing AI head icon on a digital network interface with connected tech symbols.

88635-1800x900

revvity-signals-logo-1

Revvity Signals

Learn why data quality, governance, and collaboration are critical to realizing AI&rsquo;s potential across the drug discovery pipeline.

RareCyte

Content by RareCyte

From spatial transcriptomics to spatial protein profiling

RareCyte® announces research grant to investigate molecular profile of circulating trophoblasts in fetal growth restriction

Optimizing spatial proteomics for discovery and translational research

Exploring new frontiers in pancreatic cancer treatment with spatial biology

Subscribe to our eNewsletters

Sponsored

December 2025